Panagiotou, E.; Georganta, A.; Garoflos, E.; Karaviti, E.; Karaviti, D.; Kontogiannis, A.; Chorianopoulou, S.; Kotteas, E.; Syrigos, N.; Peppa, M.
Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients. J. Pers. Med. 2026, 16, 140.
https://doi.org/10.3390/jpm16030140
AMA Style
Panagiotou E, Georganta A, Garoflos E, Karaviti E, Karaviti D, Kontogiannis A, Chorianopoulou S, Kotteas E, Syrigos N, Peppa M.
Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients. Journal of Personalized Medicine. 2026; 16(3):140.
https://doi.org/10.3390/jpm16030140
Chicago/Turabian Style
Panagiotou, Emmanouil, Anastasia Georganta, Efstathios Garoflos, Eleftheria Karaviti, Dimitra Karaviti, Athanasios Kontogiannis, Sofia Chorianopoulou, Elias Kotteas, Nikolaos Syrigos, and Melpomeni Peppa.
2026. "Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients" Journal of Personalized Medicine 16, no. 3: 140.
https://doi.org/10.3390/jpm16030140
APA Style
Panagiotou, E., Georganta, A., Garoflos, E., Karaviti, E., Karaviti, D., Kontogiannis, A., Chorianopoulou, S., Kotteas, E., Syrigos, N., & Peppa, M.
(2026). Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients. Journal of Personalized Medicine, 16(3), 140.
https://doi.org/10.3390/jpm16030140
